Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 97OTHER 53NIH 3NETWORK 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Oropharyngeal Neoplasms 1Oligometastatic Squamous Cell Carcinoma of the Head and Neck 1Neoplasm, Residual 1Mouth Neoplasms 1Mesothelioma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hodgkin Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Radiotherapy 9Radiosurgery 6Oxaliplatin 5Cisplatin 5Paclitaxel 4Capecitabine 4Leucovorin 3Irinotecan 3Fluorouracil 3Doxorubicin 3Docetaxel 3strontium chloride 2regorafenib 2pembrolizumab 2enzalutamide 2Zoledronic Acid 2Temozolomide 2Radiofrequency Ablation 2Mitomycin 2Methods 2Ifosfamide 2Gemcitabine 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Bleomycin 2Bevacizumab 2Analgesia 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neoplasm Metastasis × pembrolizumab × Clear all
NCT03260712 2023-11-03

Pembrolizumab in Biliary Tract Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
50 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis

NCT02129556 2019-02-15

PANACEA

ETOP IBCSG Partners Foundation

Phase 1/2 Completed
58 enrolled 16 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡